A look at Chromadex Corp’s (CDXC) recent performance gives investors their first glimpse of hope.

A new trading day began on Monday, with Chromadex Corp (NASDAQ: CDXC) stock price down -3.46% from the previous day of trading, before settling in for the closing price of $5.49. CDXC’s price has ranged from $1.36 to $7.97 over the past 52 weeks.

Over the past five-year period, the growth rate of yearbook sales for the company of the Consumer Defensive sector was 22.27%. Meanwhile, its annual earnings per share averaged 157.14%. With a float of $48.36 million, this company’s outstanding shares have now reached $76.03 million.

Considering the fact that the conglomerate employs 106 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 55.76%, operating margin of 2.42%, and the pretax margin is 1.47%.

Chromadex Corp (CDXC) Insider Activity

As we move forward, let’s examine how large-scale investors are investing in this stock of the Packaged Foods Industry. The insider ownership of Chromadex Corp is 36.68%, while institutional ownership is 23.28%. The most recent insider transaction that took place on Dec 13 ’24, was worth 229,956. In this transaction Director of this company sold 37,161 shares at a rate of $6.19, taking the stock ownership to the 244,179 shares. Before that another transaction happened on Dec 13 ’24, when Company’s affiliate proposed sale 37,161 for $6.19, making the entire transaction worth $229,961.

Chromadex Corp (CDXC) Earnings and Forecasts

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.02 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 157.14% per share during the next fiscal year.

Chromadex Corp (NASDAQ: CDXC) Trading Performance Indicators

Here are Chromadex Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.48. Likewise, its price to free cash flow for the trailing twelve months is 103.48.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.02, a number that is poised to hit 0.02 in the next quarter and is forecasted to reach 0.13 in one year’s time.

Technical Analysis of Chromadex Corp (CDXC)

Compared to the last year’s volume of 0.56 million, its volume of 0.8 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 6.37%. Additionally, its Average True Range was 0.39.

During the past 100 days, Chromadex Corp’s (CDXC) raw stochastic average was set at 50.88%, which indicates a significant increase from 1.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.47% in the past 14 days, which was lower than the 101.87% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $5.85, while its 200-day Moving Average is $3.88. Nevertheless, the first resistance level for the watch stands at $5.46 in the near term. At $5.61, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.72. If the price goes on to break the first support level at $5.20, it is likely to go to the next support level at $5.09. Should the price break the second support level, the third support level stands at $4.94.

Chromadex Corp (NASDAQ: CDXC) Key Stats

With a market capitalization of 410.81 million, the company has a total of 76,383K Shares Outstanding. Currently, annual sales are 83,570 K while annual income is -4,940 K. The company’s previous quarter sales were 25,580 K while its latest quarter income was 1,880 K.